Mucus Relief Tablet, Extended Release
NDC Package 72090-012-01
Package Information
Mucus Relief (guaifenesin) tablets is •do not crush, chew, or break tablet•take with a full glass of water•this product can be administered without regard for the timing of meals•adults and children 12 years of age and over: 1 tablet every 12 hours. This formulation utilizes a tablet, extended release delivery system. Marketed by Pioneer Life Sciences, Llc, this product is identified by NDC 72090-012 and is authorized under FDA application ANDA213420.
Identification & Billing
- RxCUI: 310621 - guaiFENesin 1200 MG 12HR Extended Release Oral Tablet
- RxCUI: 310621 - 12 HR guaifenesin 1200 MG Extended Release Oral Tablet
- RxCUI: 310621 - guaifenesin 1200 MG 12 HR Extended Release Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 72090 - Pioneer Life Sciences, Llc
- 72090-012 - Mucus Relief
- 72090-012-01 - 100 TABLET, EXTENDED RELEASE in 1 BOTTLE
- 72090-012 - Mucus Relief
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (72090-012). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 72090-012-01 identifies a specific commercial package of 100 tablet, extended release in 1 bottle of Mucus Relief, a human over the counter drug labeled by Pioneer Life Sciences, Llc. This tablet, extended release is formulated for oral use and contains guaifenesin as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Pioneer Life Sciences, Llc on December 04, 2025. The current certification is valid through December 31, 2026.
How is this Pioneer Life Sciences, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 72090001201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.